US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Invesco Nasdaq Biotechnology ETF

36.30

+0.51001.42%

Post-market: 36.470.1700+0.47%18:40 EDT

Volume:17.89K

Turnover:646.73K

Market Cap:98.74M

PE:- -

High:36.45

Open:35.93

Low:35.75

Close:35.79

52wk High:36.84

52wk Low:23.42

Shares:2.72M

Float Shares:2.72M

Volume Ratio:0.59

T/O Rate:0.66%

Dividend:0.26

Dividend Rate:0.71%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Apichope's Subsidiary Gains Regulatory Nod for Novel Drug Trial Application

When This Sector Rallies, Tech Takes a Backseat

Gilead (GILD) Stock Still Looks Below Fair Value As Court Backs HIV Import Block

Simply Wall St.

Gilead Sciences Inc. Stock Underperforms Thursday When Compared to Competitors

Moderna Inc. Stock Slips 23.5%, Underperforms Peers

Vertex Advances Kidney Disease Pipeline With Completed Inaxaplin Phase 2b Trial

Daily ETF Wrap: Innovative Drugs and CXO Remain the Two Brightest Investment Themes in the Healthcare Sector

Unexpected Surge: Moderna Jumps 177% on Historic Cancer Vaccine Breakthrough, Sending ASX and Hong Kong Biotech Stocks Soaring

Wall Street Analysts Are Bullish on Top Healthcare Picks

The Real Market Driver Right Now Might Surprise You

HENGRUI PHARMA (01276) Gets Clinical Trial Approval for SHR-7012 Injection Targeting Cutaneous Lupus Erythematosus

Sino Biopharmaceutical Stock Climbs 13% in Hong Kong, Outperforms Competitors

ST-Humanwell Advances RFUS-188 Injection into Phase II Clinical Study

U.S. Research Roundup-Amgen, Analog Devices, Moderna

Sweden's Medivir Q2 Turnover Falls

Hong Kong Stock Market Flash | SIMCERE PHARMA (02096) Surges Over 5% in Morning Session Ahead of Interim Results Release

Record Earnings From Industry Leaders Signal Peak Season for Innovative Drug Mid-Year Reports?

Vertex Resource Group Boosts Profitability and Cash Flow in Q2 2026

Telix Swings to H1 FY26 Net Profit of US$38 Million; Revenue Rises 22% to Us$477 Million

Press Release: Vertex Resource Group Ltd. Reports Second Quarter 2026 Results

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigermoments.com/stock/IBBQ/news?page=8"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IBBQ","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBBQ\",,,,,undefined,":{"symbol":"IBBQ","market":"US","secType":"STK","nameCN":"Invesco Nasdaq Biotechnology ETF","latestPrice":36.3,"timestamp":1788379200000,"preClose":35.79,"halted":0,"volume":17889,"hourTrading":{"tag":"盘后","latestPrice":36.47,"preClose":36.3,"latestTime":"18:40 EDT","volume":170,"amount":6173.00056,"timestamp":1788388831406,"change":0.17,"changeRate":0.004683,"amplitude":0.004683},"delay":0,"changeRate":0.014249790444258118,"floatShares":2720001,"shares":2720001,"eps":0,"marketStatus":"Post-Mkt","change":0.51,"latestTime":"09-02 18:52:59 EDT","open":35.93,"high":36.45,"low":35.7472,"amount":646726.473243,"amplitude":0.019637,"askPrice":36.52,"askSize":8200,"bidPrice":34.31,"bidSize":8700,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1788393600000},"marketStatusCode":4,"adr":0,"exchange":"NASDAQ","adjPreClose":35.79,"sharesOutstanding":2520001,"nav":35.43802,"aum":96391449.83802,"dividendRate":0.007052,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":35.79,"preClose":35.79,"latestTime":"07:00 EDT","volume":100,"amount":3579.2799999999997,"timestamp":1788346812804,"change":0,"changeRate":0,"amplitude":0.007823},"postHourTrading":{"tag":"盘后","latestPrice":36.47,"preClose":36.3,"latestTime":"18:40 EDT","volume":170,"amount":6173.00056,"timestamp":1788388831406,"change":0.17,"changeRate":0.004683,"amplitude":0.004683},"volumeRatio":0.585304,"impliedVol":0.1027,"impliedVolPercentile":0.4246},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBBQ\",,,,,undefined,":{"symbol":"IBBQ","floatShares":2720001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.585304,"shares":2720001,"dividePrice":0.256,"high":36.45,"amplitude":0.019637,"preClose":35.79,"low":35.7472,"week52Low":23.42,"pbRate":"--","week52High":36.84,"institutionHeld":0,"latestPrice":36.3,"committee":0.029586,"eps":0,"divideRate":0.007052,"volume":17889,"delay":0,"ttmEps":0,"open":35.93,"prevYearClose":28.3962,"prevWeekClose":35.47,"prevMonthClose":35.4742,"prevQuarterClose":32.66,"fiveDayClose":36.57,"twentyDayClose":32.93,"sixtyDayClose":28.77},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IBBQ\",params:#limit:5,,,undefined,":[{"date":"2026-06-22","symbol":"IBBQ","amount":0.03422,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-26","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-26"},{"date":"2026-03-23","symbol":"IBBQ","amount":0.03609,"announcedDate":"2026-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-23","defaultRemindTime":1774272600000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-27","payableDate":"2026-03-23","currency":"USD","dateTimestamp":1774238400000,"payDate":"2026-03-27"},{"date":"2025-12-22","symbol":"IBBQ","amount":0.0906,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2025-09-22","symbol":"IBBQ","amount":0.09576,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-26","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-26"},{"date":"2025-06-23","symbol":"IBBQ","amount":0.0287,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-27","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-27"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IBBQ\",market:\"US\",,,undefined,":[{"executeDate":"2021-09-20","recordDate":"2021-09-21","paymentDate":"2021-09-30","value":0.04324,"currency":"USD"},{"executeDate":"2021-12-20","recordDate":"2021-12-21","paymentDate":"2021-12-31","value":0.10511,"currency":"USD"},{"executeDate":"2022-03-21","recordDate":"2022-03-22","paymentDate":"2022-03-31","value":0.03778,"currency":"USD"},{"executeDate":"2022-06-21","recordDate":"2022-06-22","paymentDate":"2022-06-30","value":0.04264,"currency":"USD"},{"executeDate":"2022-09-19","recordDate":"2022-09-20","paymentDate":"2022-09-23","value":0.03769,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IBBQ\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IBBQ\",pageSize:20,pageCount:8,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1158851231","title":"Apichope's Subsidiary Gains Regulatory Nod for Novel Drug Trial Application","url":"https://stock-news.laohu8.com/highlight/detail?id=1158851231","media":"Stock News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158851231?lang=en_us&edition=fundamental","pubTime":"2026-08-21 11:52","pubTimestamp":1787284333,"startTime":"0","endTime":"0","summary":"Apichope Pharmaceutical Group Co., Ltd. (300723.SZ) announced that its wholly-owned subsidiary, Guangzhou Yipinhong Pharmaceutical Co., Ltd., has received approval from the National Medical Products...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06978","LNGR","MDTX","300723","IBBQ","BMED","MEDX","BK1574","IBBJ","BK0239","BK1161","PSYK","159992"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165297527","title":"When This Sector Rallies, Tech Takes a Backseat","url":"https://stock-news.laohu8.com/highlight/detail?id=1165297527","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165297527?lang=en_us&edition=fundamental","pubTime":"2026-08-21 09:10","pubTimestamp":1787274639,"startTime":"0","endTime":"0","summary":"On August 19th, the U.S. Treasury Department unexpectedly decided to at least double its long-term bond repurchase program, directly pushing global yields lower. While many assumed tech stocks would...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GCmain","SGUmain","SGCmain","518880","06978","BK1574","159934","LNGR","IBBQ","GLD","NUGT","BK1161","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661923014","title":"Gilead (GILD) Stock Still Looks Below Fair Value As Court Backs HIV Import Block","url":"https://stock-news.laohu8.com/highlight/detail?id=2661923014","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661923014?lang=en_us&edition=fundamental","pubTime":"2026-08-21 04:35","pubTimestamp":1787258134,"startTime":"0","endTime":"0","summary":"Gilead Sciences stock has delivered very strong long term returns over the past five years, yet current valuation checks and market multiples still point to the shares screening as undervalued. With recent news flow focused on its HIV and oncology franchises and on legal protection of its U.S. drug pricing, investors are weighing how much of this is already reflected in the price.\n\nGilead Sciences has returned 148.1% over the past five years, which puts recent valuation questions in the...","market":"hk","thumbnail":"https://images.simplywall.st/asset/company-cover/29002-main-header/1756252861953","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/29002-main-header/1756252861953"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gild/gilead-sciences/news/gilead-gild-stock-still-looks-below-fair-value-as-court-back","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gild/gilead-sciences/news/gilead-gild-stock-still-looks-below-fair-value-as-court-back","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU1430594728.SGD","LU0965509010.AUD","LU2112291526.USD","LU0122379950.USD","IE00BKVL7J92.USD","GILD","BK4550","SG9999015986.USD","LU1934455194.USD","LU1934455277.USD","LU0114720955.EUR","IBBQ","IBB","IE00BSNM7G36.USD","LU2089984988.USD","LU0965509283.SGD","CDIG","LU1934455863.HKD","LU1057294990.SGD","BK4566","MEDI","LU2087621335.USD","LU1037948541.HKD","BK4588","LU0861579265.USD","IE00BZ1G4Q59.USD","LU1066051498.USD","LU0823416689.USD","BMED","LU1778281490.HKD","LU0889565916.HKD","IE00B19Z3581.USD","IE0002270589.USD","LU0109394709.USD","LU0965508806.USD","TACU","TMED","IE00B19Z3B42.SGD","SG9999015945.SGD","TSPA","BK4585","BBH","LU1037948897.HKD","TBXU","SG9999015978.USD","DAPP","LU0320765992.SGD","LU2468319806.SGD","LU0289739699.SGD","BIB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661232279","title":"Gilead Sciences Inc. Stock Underperforms Thursday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2661232279","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661232279?lang=en_us&edition=fundamental","pubTime":"2026-08-21 04:35","pubTimestamp":1787258100,"startTime":"0","endTime":"0","summary":"DJ Gilead Sciences Inc. Stock Underperforms Thursday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Gilead Sciences Inc.  slipped 2.82% to $143.44 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index  falling 0.87% to 7,641.16 and Dow Jones Industrial Average  falling 1.32% to 52,759.21.The stock's fall snapped a seven-day winning streak.Gilead Sciences Inc. closed 8.81% below its 52-week high of $157.29, which the company achieved on February 11th.The stock underperformed when compared to some of its competitors Thursday, as Johnson & Johnson  fell 2.21% to $267.37, Pfizer Inc.  fell 1.59% to $27.79, and Abbott Laboratories  fell 0.25% to $114.14.Trading volume  remained 286,153 below its 50-day average volume of 7.4 M.Data source: Dow Jones Market Data, FactSet. Data compiled August 20, 2026.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0882574055.USD","LU0965509283.SGD","LU1934455277.USD","BK4578","IE00B7SZLL34.SGD","LU0109394709.USD","BK4583","SG9999015978.USD","LU0861579265.USD","TMED","LU0114720955.EUR","LU0823416689.USD","SG9999015986.USD","LU2468319806.SGD","LU1674673691.USD","BK4139","LU0965509010.AUD","LU1571399168.USD","LU2087621335.USD","MEDI","LU1430594728.SGD","SG9999015952.SGD","LU0965509101.SGD","LU2324357040.USD","IE00B3T34201.USD","LU1839511570.USD","LU1934455194.USD","IE00BZ1G4Q59.USD","TBXU","IE0002270589.USD","LU0122379950.USD","LU1061106388.HKD","LU1037948897.HKD","LU1934455863.HKD","LU1023059063.AUD","LU1066051498.USD","BK4588","IE00BKVL7J92.USD","LU0965508806.USD","LU2089984988.USD","LU0058720904.USD","BK4550","LU1778281490.HKD","LU2112291526.USD","LU1037948541.HKD","IBBQ","LU1674673428.USD","LU1066053197.SGD","LU0289739699.SGD","IE00B19Z3581.USD","BK4585","LU0234570918.USD","SG9999015945.SGD","BK4532","GILD","LU1057294990.SGD","LU1585245621.USD","BK4568","LU0889565916.HKD","LU0320765992.SGD","BIB","IBB","BK4566","BBH","IE00BSNM7G36.USD","IE00B19Z3B42.SGD","BMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661232427","title":"Moderna Inc. Stock Slips 23.5%, Underperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2661232427","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661232427?lang=en_us&edition=fundamental","pubTime":"2026-08-21 04:33","pubTimestamp":1787257980,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. cratered 23.5% to $133.32 on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index falling 1.0% to 26,067.17 and Dow Jones Industrial Average falling 1.3% to 52,759.21.Moderna Inc. closed 24.5% short of its 52-week high of $176.66, which the company reached on August 19th.The stock underperformed when compared to some of its peers, as Johnson & Johnson fell 2.2% to $267.37, Pfizer Inc. fell 1.6% to $27.79, and Gilead Sciences Inc. fell 2.82% to $143.44.Trading volume totaled 97.3 million, compared to the 50-day average of 11.2 million.Data source: Dow Jones Market Data, FactSet","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4550","LU0823416689.USD","MRNA","LU1430594728.SGD","LU0289739699.SGD","LU0882574055.USD","LGHT","SG9999015945.SGD","TMED","LU1037948541.HKD","LU1585245621.USD","BK4566","IE00B7SZLL34.SGD","IE00B19Z3B42.SGD","LU0109394709.USD","BIB","BBH","IDNA","BK4551","BMED","GILD","IE00BSNM7G36.USD","BK4578","BK4532","LU1066053197.SGD","LU0058720904.USD","LU1023059063.AUD","LU1934455194.USD","LU1778281490.HKD","LU2324357040.USD","LU2468319806.SGD","IBB","LU1839511570.USD","MEDI","TBXU","BK4139","LU2112291526.USD","SG9999015952.SGD","IBBQ","BK4533","MRNX","LU0114720955.EUR","MRNY","LU1674673428.USD","LU1674673691.USD","WDNA","GNOM","BK4548","LU0965509010.AUD","IE00B3T34201.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661323699","title":"Vertex Advances Kidney Disease Pipeline With Completed Inaxaplin Phase 2b Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2661323699","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661323699?lang=en_us&edition=fundamental","pubTime":"2026-08-21 00:30","pubTimestamp":1787243431,"startTime":"0","endTime":"0","summary":"Vertex Pharmaceuticals Inc. ($VRTX) announced an update on their ongoing clinical study. The Phase 2b study A Phase 2b, Open-label Study to Evaluat...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vertex-advances-kidney-disease-pipeline-with-completed-inaxaplin-phase-2b-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vertex-advances-kidney-disease-pipeline-with-completed-inaxaplin-phase-2b-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VERX","LU2362541513.USD","LU1674673428.USD","LU2362540622.SGD","BK4567","IBBQ","BK4588","IE00B19Z9P08.USD","SG9999001176.USD","LU0757428866.USD","IE00BJJMRZ35.SGD","IE00B19Z3B42.SGD","SGXZ57979304.SGD","LU0889565916.HKD","IE00B2B36J28.USD","IDNA","IE00B19Z3581.USD","LU2324357040.USD","SG9999013999.USD","LU0566484027.USD","TBXU","VRTX","BK4139","LU2362541273.HKD","PBE","LU1093756325.SGD","LU1815336091.USD","LU0234570918.USD","LU2417539215.USD","LU1093756168.USD","IE0002141913.USD","LU2468319806.SGD","BK4585","LU1069344957.HKD","LU2456880835.USD","LU1674673691.USD","LU0289739699.SGD","LU0256863811.USD","LU0079474960.USD","BIB","IE00BFTCPJ56.SGD","IE0009355771.USD","LU2237438978.USD","IE00B894F039.SGD","SG9999001176.SGD","BBH","LU2089984988.USD","LU0432979614.USD","IBB","GNMX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167838800","title":"Daily ETF Wrap: Innovative Drugs and CXO Remain the Two Brightest Investment Themes in the Healthcare Sector","url":"https://stock-news.laohu8.com/highlight/detail?id=1167838800","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167838800?lang=en_us&edition=fundamental","pubTime":"2026-08-20 21:15","pubTimestamp":1787231758,"startTime":"0","endTime":"0","summary":"Domestic A-shares staged a rebound today, with major indices closing in positive territory. By the close, the Shanghai Composite Index rose 0.24% to 3,903.72 points, the Shenzhen Component Index...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159992","WX","06978","BK1574","LNGR","BK4585","FDN","MEDX","BK1515","BK1161","BK4550","159938","BK4588","09939","CXO","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1135230362","title":"Unexpected Surge: Moderna Jumps 177% on Historic Cancer Vaccine Breakthrough, Sending ASX and Hong Kong Biotech Stocks Soaring","url":"https://stock-news.laohu8.com/highlight/detail?id=1135230362","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1135230362?lang=en_us&edition=fundamental","pubTime":"2026-08-20 21:11","pubTimestamp":1787231517,"startTime":"0","endTime":"0","summary":"In a market move that has caught many by surprise, biotech giant Moderna experienced a staggering single-day surge of 177% this week, following the release of highly anticipated clinical trial data....","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["399300","LNGR","83188","82846","BK1574","07233","159992","BK4585","IBBQ","BK1147","BK4588","03188","VXUS","03130","02827","159982","06978","02846","83130","BK1161","MEDX","KCAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660728971","title":"Wall Street Analysts Are Bullish on Top Healthcare Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2660728971","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660728971?lang=en_us&edition=fundamental","pubTime":"2026-08-20 19:40","pubTimestamp":1787226007,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Vertex Pharmaceuticals (VRTX), Glaukos (GKOS) and Ve...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-306?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-306?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0417517546.SGD","LU1093756325.SGD","GNMX","IE00BFTCPJ56.SGD","LU2362540622.SGD","LU0256863811.USD","IE00B19Z9Z06.USD","IE0009354923.USD","LU2362541273.HKD","GKOS","PBE","BIB","LU0058720904.USD","BK4548","LU1878469433.USD","SG9999001176.USD","BK4082","LU0061475181.USD","LU2236285917.USD","IBBQ","LU0432979614.USD","BK4532","IE00B4R5TH58.HKD","IE00BZ9MQY76.HKD","BK4588","IE00BJT1NW94.SGD","SG9999013999.USD","IE0002270589.USD","IE0009355771.USD","LU1674673691.USD","LU1035775433.USD","BK4585","IDNA","LU1585245621.USD","IE00B19Z3B42.SGD","LU0823416689.USD","LU1430594728.SGD","LU2417539215.USD","LU1069344957.HKD","LU2324357040.USD","IE00B2B36J28.USD","IE00B19Z3581.USD","LU2237438978.USD","IE00BJJMRZ35.SGD","LU2468319806.SGD","BK4567","LU1093756168.USD","BBH","LU1674673428.USD","IE0002141913.USD","LU2065731478.USD","TBXU","LU1778281490.HKD","LU0234570918.USD","IE00B894F039.SGD","LU0289739699.SGD","LU0320765992.SGD","BK4533","LU2456880835.USD","IE00B19Z9P08.USD","LU2362541513.USD","LU2462157665.USD","IBB","VRTX","SG9999001176.SGD","LU2089984988.USD","LU0889565916.HKD","LU0079474960.USD","BK4139","SGXZ57979304.SGD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1163518027","title":"The Real Market Driver Right Now Might Surprise You","url":"https://stock-news.laohu8.com/highlight/detail?id=1163518027","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1163518027?lang=en_us&edition=fundamental","pubTime":"2026-08-20 18:40","pubTimestamp":1787222435,"startTime":"0","endTime":"0","summary":"China's A-share market posted a modest overall gain today (August 20), yet a clear divergence is emerging beneath the surface. Stocks tied to innovative drugs are celebrating, while tech sectors are...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDX","BK1574","LNGR","IBBQ","OCS","BK4007","06978","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130698825","title":"HENGRUI PHARMA (01276) Gets Clinical Trial Approval for SHR-7012 Injection Targeting Cutaneous Lupus Erythematosus","url":"https://stock-news.laohu8.com/highlight/detail?id=1130698825","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130698825?lang=en_us&edition=fundamental","pubTime":"2026-08-20 18:26","pubTimestamp":1787221594,"startTime":"0","endTime":"0","summary":"HENGRUI PHARMA (01276) has announced that its subsidiary, Guangdong Hengrui Pharmaceuticals Co., Ltd., has received the Drug Clinical Trial Approval Notice issued by the National Medical Products...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","LU2148510915.USD","LU1255011170.USD","LU1064130708.USD","LU2097828474.EUR","LU0359202008.SGD","LU1064131003.USD","MDTX","LU2495084118.USD","BMED","LU2580892862.HKD","BK0239","LU2097828805.USD","LU1023057109.AUD","IBBQ","LU1781817850.SGD","LU0405327494.USD","BK0012","LU2289578879.USD","LU2328871848.SGD","LU2097828631.EUR","LU1820825898.SGD","BK0028","BK0183","PSYK","LU2543165471.USD","LU1146622755.USD","LU2488822045.USD","LU0359201612.USD","LU1655091616.SGD","LU1997245094.SGD","LU1328615791.USD","LU1580142542.USD","LU2580892789.USD","LU2097828557.USD","BK0188","LU2097828714.EUR","BK0060","600276","BK0196","IBBJ","LU1997245177.USD","01276","LU0405327148.USD","LU0359201885.HKD","LU1969619763.USD","LU1997244956.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660402506","title":"Sino Biopharmaceutical Stock Climbs 13% in Hong Kong, Outperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2660402506","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660402506?lang=en_us&edition=fundamental","pubTime":"2026-08-20 16:31","pubTimestamp":1787214660,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. surged 13% to 5.39 Hong Kong dollars on what proved to be an all-around great trading session for the Hong Kong stock market, with the Hang Seng Index rising 0.8% to 25698.49.The stock's rise snapped a two-day losing streak.Sino Biopharmaceutical Ltd. closed 41% short of its 52-week high of HK$9.12, which the company achieved Sept. 10.The stock outperformed some of its competitors, as CSPC Pharmaceutical Group Ltd. rose 9.6% and Amgen Inc. remained unchanged.Trading volume totaled 382.5 million shares, compared to the 50-day average of 95.1 million shares.Data source: Dow Jones Market Data, FactSet","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","LU1571399168.USD","LU0122379950.USD","IE00BZ08YR35.GBP","IE00BJT1NW94.SGD","BK4581","LU2242646821.SGD","AMGN","LU0109394709.USD","IE0009355771.USD","LU2089984988.USD","BK4533","IE00BJJMRZ35.SGD","LU1023059063.AUD","PJP","BK4585","IBB","IE0002141913.USD","BBH","01177","LU0058720904.USD","IBBQ","LU0289739699.SGD","LU1057294990.SGD","LU0889565916.HKD","LU2242652126.USD","BK4139","IE00BFTCPJ56.SGD","LU2112291526.USD","SG9999001440.SGD","LU1983299246.USD","BK4588","BK1589","HK0000165453.HKD","LU0320765992.SGD","TBXU","LU1061106388.HKD","IE00B4R5TH58.HKD","BK4599","LU2468319806.SGD","LU0868494617.USD","BK1191","IE00B2B36J28.USD","IE00BZ08YS42.EUR","BIB","PBE","BK1521","BK4566","BK1515","IE00BZ08YT58.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189611181","title":"ST-Humanwell Advances RFUS-188 Injection into Phase II Clinical Study","url":"https://stock-news.laohu8.com/highlight/detail?id=1189611181","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1189611181?lang=en_us&edition=fundamental","pubTime":"2026-08-20 15:54","pubTimestamp":1787212466,"startTime":"0","endTime":"0","summary":"ST-Humanwell (600079.SH) has announced that its majority-owned subsidiary, Yichang Humanwell Pharmaceutical Co., Ltd. (in which the company holds an 80% stake), recently disclosed the Phase II...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0188","IBBQ","IBBJ","BK0028","BK0070","BK0239","BK0185","BK0012","BMED","BK0096","MDTX","PSYK","600079"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660811404","title":"U.S. Research Roundup-Amgen, Analog Devices, Moderna","url":"https://stock-news.laohu8.com/highlight/detail?id=2660811404","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660811404?lang=en_us&edition=fundamental","pubTime":"2026-08-20 15:47","pubTimestamp":1787212055,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Amgen, Analog Devices, ModernaAug 20 (Reuters)-Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Amgen, Analog D","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nL4N44H0HP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EL","ARTY","MRK","PGR","NIQ","WISE","ABBV","XNTK","MRNA","IHE","SPHR","CRWD","KIDS","ADI","SNOW","EPR","XLV","APA","CING","PCTY","PJP","BILL","ALIT","ALL","WDAY","AIPI","WHD","RARE","MRVL","TJX","FRNM","IBBQ","HCA","LOW","UNCY","WOLF","AMGN","LNSR","IHF","KBWP","MSGE","ADSK","GKOS","SMHX","LWAY","NRGV","RLAY","TRUH","TGT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660340609","title":"Sweden's Medivir Q2 Turnover Falls","url":"https://stock-news.laohu8.com/highlight/detail?id=2660340609","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660340609?lang=en_us&edition=fundamental","pubTime":"2026-08-20 14:41","pubTimestamp":1787208103,"startTime":"0","endTime":"0","summary":"Sweden's Medivir Q2 turnover fallsOverviewSweden drug developer's Q2 net turnover declined yr/yr, EBITDA loss narrowedCompany completed SEK 140 mln share issue to fund rare bone disease drug developme","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nL1N44H07I:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1720051108.HKD","LU2089984988.USD","FLEL","LU1974910355.USD","LU2272731782.SGD","BK4512","LU2322448957.HKD","IBB","REGN","LU0823434740.USD","LU0289739699.SGD","BK4139","LU0208291251.USD","TBXU","BBH","LU0057025933.USD","LU0289739343.SGD","LU2473716301.USD","LU1992135472.HKD","LU1366192091.USD","BK4585","FLEX","LU0823416689.USD","LU1720051017.SGD","LU2106854487.HKD","LU2362541513.USD","LU0058720904.USD","LU2468319806.SGD","LU1917777945.USD","LU2272731600.USD","LU0889565916.HKD","BK4588","LU0289960550.SGD","LU0114720955.EUR","LU0069063385.USD","LU0511384066.AUD","LU1303367103.USD","LU2357305700.SGD","LU0320765489.SGD","LU2237438978.USD","LU0053666078.USD","LU2362540622.SGD","LU0109394709.USD","LU2362541273.HKD","LU2322448791.USD","LU0823434583.USD","LU0963586101.USD","LU2272731865.HKD","LU2023250504.SGD","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102229692","title":"Hong Kong Stock Market Flash | SIMCERE PHARMA (02096) Surges Over 5% in Morning Session Ahead of Interim Results Release","url":"https://stock-news.laohu8.com/highlight/detail?id=1102229692","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1102229692?lang=en_us&edition=fundamental","pubTime":"2026-08-20 10:36","pubTimestamp":1787193374,"startTime":"0","endTime":"0","summary":"SIMCERE PHARMA (02096) jumped more than 5% in early trading on Wednesday, with shares last up 4.27% at HK$12.69, recording a turnover of HK$40.17 million. The stock's upward momentum comes as...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BD","VXUS","BK1191","06978","BK4585","BK1574","LNGR","KCAI","BK4588","IBBQ","02096","159992","BK1583","BK1161","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192579782","title":"Record Earnings From Industry Leaders Signal Peak Season for Innovative Drug Mid-Year Reports?","url":"https://stock-news.laohu8.com/highlight/detail?id=1192579782","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192579782?lang=en_us&edition=fundamental","pubTime":"2026-08-20 10:30","pubTimestamp":1787193031,"startTime":"0","endTime":"0","summary":"Strong financial results from sector frontrunners are fueling market optimism, with many innovative drug companies poised to deliver their most impressive interim reports yet.A bullish technical...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDX","159992","BK1161","BK1574","LNGR","IBBQ","06978"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660479477","title":"Vertex Resource Group Boosts Profitability and Cash Flow in Q2 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2660479477","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660479477?lang=en_us&edition=fundamental","pubTime":"2026-08-20 07:37","pubTimestamp":1787182673,"startTime":"0","endTime":"0","summary":"Vertex Resource Group Ltd. ( ($TSE:VTX) ) has issued an update. Vertex Resource Group Ltd. reported stronger second-quarter 2026 results, highlight...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vertex-resource-group-boosts-profitability-and-cash-flow-in-q2-2026?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vertex-resource-group-boosts-profitability-and-cash-flow-in-q2-2026?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SG9999013999.USD","LU0320765992.SGD","BK4533","LU0256863811.USD","LU2462157665.USD","LU0889565916.HKD","LU0234570918.USD","LU1093756168.USD","SGXZ57979304.SGD","IE00B19Z9Z06.USD","IBB","BK4585","IE0002141913.USD","LU1035775433.USD","PBE","LU1093756325.SGD","LU2456880835.USD","IE0002270589.USD","SG9999001176.SGD","IE00BJT1NW94.SGD","LU1778281490.HKD","IE00BZ9MQY76.HKD","LU1815336091.USD","LU2237438978.USD","LU0566484027.USD","IE00B4R5TH58.HKD","LU2089984988.USD","IBBQ","BIB","GNMX","IDNA","VRTX","TBXU","IE00BFTCPJ56.SGD","BBH","IE00B19Z3581.USD","IE0009355771.USD","BK4532","SG9999001176.USD","LU0061475181.USD","BK4023","IE00B19Z9P08.USD","LU2362541513.USD","LU2468319806.SGD","LU0289739699.SGD","VERX","IE00BJJMRZ35.SGD","LU0058720904.USD","BK4588","LU2236285917.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660796854","title":"Telix Swings to H1 FY26 Net Profit of US$38 Million; Revenue Rises 22% to Us$477 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2660796854","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660796854?lang=en_us&edition=fundamental","pubTime":"2026-08-20 07:10","pubTimestamp":1787181028,"startTime":"0","endTime":"0","summary":"Telix swings to H1 FY26 net profit of US$38 million; revenue rises 22% to US$477 millionTelix Pharmaceuticals reported H1 2026 revenue of US$477 million, up 22% year over year.Net profit swung to US$3","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nNDLbYKwmX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU0289739699.SGD","LU2468319806.SGD","BBH","BK7067","LU0823416689.USD","LU0823434740.USD","TLX.AU","LU0058720904.USD","LU1974910355.USD","LU0053666078.USD","BK4139","LU2106854487.HKD","LU2023250504.SGD","LU2237438978.USD","LU2362541273.HKD","IBB","LU0823434583.USD","LU2089984988.USD","LU1917777945.USD","LU0109394709.USD","LU0889565916.HKD","LU0882574055.USD","TBXU","LU2362540622.SGD","IBBQ","LU2362541513.USD","LU0114720955.EUR","BK4588","LU0320765992.SGD","REGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660282476","title":"Press Release: Vertex Resource Group Ltd. Reports Second Quarter 2026 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2660282476","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660282476?lang=en_us&edition=fundamental","pubTime":"2026-08-20 06:31","pubTimestamp":1787178660,"startTime":"0","endTime":"0","summary":"Profit margin %                           28 %       24 %      26 %      23 %. Adjusted EBITDA %                         18 %       13 %      15 %      11 %.   See \"Non-IFRS Financial Measures\"HIGHLIGHTS FOR THE THREE MONTHS ENDED JUNE 30, 2026-- Net revenue increased $1.0 million over prior period while G&A expenses. -- Profit margin improved to 28.4% of net revenue, up from 24.3% in 2025.-- Adjusted EBITDA increased by $2.8 million, or 43.8%, compared to 2025,with Adjusted EBITDA growth in both the Environmental Consulting and. -- Returned to profitability with net income of $1.0 million, representing a. -- Free cash flow increased to $4.6 million from $1.3 million in Q2 2025.HIGHLIGHTS FOR THE SIX MONTHS ENDED JUNE 30, 2026-- Environmental Consulting net revenue increased by 7.8% compared to H1. -- G&A expenses were reduced by 6.5% compared to H1 2025.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B2B36J28.USD","LU1815336091.USD","IBB","IE00B19Z9Z06.USD","IDNA","LU0566484027.USD","LU0058720904.USD","LU2456880835.USD","IE00BJT1NW94.SGD","LU0061475181.USD","BIB","IE0002141913.USD","LU0417517546.SGD","BK4139","TBXU","SG9999001176.SGD","LU2468319806.SGD","IE00BFTCPJ56.SGD","LU0109394709.USD","LU1674673691.USD","VRTX","LU0889565916.HKD","LU2462157665.USD","BK4532","LU0757428866.USD","BK4588","LU0320765992.SGD","IE00B894F039.SGD","LU1069344957.HKD","LU2089984988.USD","LU0432979614.USD","GNMX","IE00BJJMRZ35.SGD","IBBQ","LU0079474960.USD","IE00B19Z9P08.USD","LU0823416689.USD","LU0256863811.USD","IE00B4R5TH58.HKD","SPHQ","BBH","SG9999013999.USD","IE00B19Z3581.USD","VERX","BK4533","PBE","SG9999001176.USD","LU1674673428.USD","LU1035775433.USD","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":8,"totalSize":200,"code":"91000000","status":"200"}]}}